Research in Lianyungang
Science Explorer records 3 research institutions in Lianyungang, China. The highest-ranked on research quality in 2022–2025 are Lianyungang Oriental Hospital, Jiangsu Hengrui Medicine (China) and Lianyungang Runzhong Pharmaceutical (China).
- Research institutions
- 3 3 of them ranked worldwide
- Research works
- 1k ▲ 91% vs 2013–17
- Top-10% rate, 2022–2025
- 16.8% record average 16.5%
A city carries no overall standing here. The composite score is built for institutions and countries, the units its floors and field normalisation were designed around. An empty rank on this page is a statement about the measure, not about the place.
Which research institutions are in Lianyungang?
| # | Institution | Works | Against the largest here | World rank |
|---|---|---|---|---|
| 1 | Lianyungang Oriental HospitalHospital / health system | 542 | #10,875 | |
| 2 | Jiangsu Hengrui Medicine (China)Company | 357 | #12,225 | |
| 3 | Lianyungang Runzhong Pharmaceutical (China)Company | 113 | #22,679 |
By fractional works over the whole record; world rank on research quality in 2022–2025. Bars are scaled to the largest institution in this city, not to anything off the page.
What is Lianyungang strongest at in research?
Relative to its size, research in Lianyungang is most concentrated in Oncology (8.2× the world share in Oncology).
- OncologySubfield · 42.2 works8.2×
Location quotient against the world baseline. Inside a single field a city is a meaningful unit, which is why this is where a city is measured at all.
Which keywords describe research in Lianyungang?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Chemotherapy, Inflammation, Tumor Microenvironment, Oxidative Stress, Targeted Therapy, Biomarkers and Breast Cancer.
- Antibody Engineering
- Immunogenicity
- Biopharmaceuticals
- Receptor tyrosine kinases
- EGFR
- Metastatic Breast Cancer
- Metastatic
- Glycosylation
- Prognostic Factors
- Immune Checkpoint Blockade
- Precision Medicine
- Clinical Practice Guidelines
- Metastasis
- Gene Expression
- Breast Cancer
- Cancer Therapy
- Immunotherapy
- Tumor Microenvironment
- Oxidative Stress
- Cancer
- Inflammation
- Chemotherapy
- Epidemiology
- Biomarkers
- Clinical Trials
- Targeted Therapy
- Monoclonal Antibodies
- Cardiovascular Disease
- Therapeutic Antibodies
- Antioxidant
- Cell Death
- PD-1 and PD-L1
- PET Imaging
- Survival Analysis
- Monoclonal Antibody
- Trastuzumab
- HER2
- Epigenetic Regulation
- Neoadjuvant Therapy
- Genomic Profiling
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this city's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation34▲ 3.6×67 topics
- Cancer34▲ 5.5×43 topics
- Chemotherapy25▲ 7.7×19 topics
- Oxidative Stress24▲ 3.2×47 topics
- Epidemiology23▲ 1.26×76 topics
- Tumor Microenvironment21▲ 10×7 topics
- Biomarkers16▲ 5.1×15 topics
- Immunotherapy16▲ 4.9×16 topics
- Clinical Trials14▲ 4.7×14 topics
- Cancer Therapy14▲ 5.2×18 topics
- Targeted Therapy13▲ 13×5 topics
- Breast Cancer13▲ 12×9 topics
- Monoclonal Antibodies12▲ 30×3 topics
- Gene Expression12▲ 4.3×13 topics
- Cardiovascular Disease12▲ 2.3×28 topics
- Metastasis10▲ 6.7×12 topics
- Therapeutic Antibodies10▲ 32×2 topics
- Clinical Practice Guidelines10▲ 3.9×14 topics
- Antioxidant9▲ 3.0×28 topics
- Precision Medicine9▲ 4.2×7 topics
- Cell Death8▲ 7.7×6 topics
- Immune Checkpoint Blockade8▲ 16×1 topic
- PD-1 and PD-L18▲ 16×1 topic
- Prognostic Factors8▲ 4.2×13 topics
- PET Imaging8▲ 10×5 topics
- Glycosylation8▲ 15×3 topics
- Survival Analysis8▲ 6.0×6 topics
- Metastatic7▲ 26×2 topics
- Monoclonal Antibody7▲ 31×2 topics
- Metastatic Breast Cancer7▲ 28×2 topics
- Trastuzumab7▲ 34×2 topics
- EGFR7▲ 53×1 topic
- HER27▲ 53×1 topic
- Receptor tyrosine kinases7▲ 43×2 topics
- Epigenetic Regulation7▲ 6.7×4 topics
- Biopharmaceuticals7▲ 28×3 topics
- Neoadjuvant Therapy7▲ 6.1×5 topics
- Immunogenicity6▲ 32×2 topics
- Genomic Profiling6▲ 13×2 topics
- Antibody Engineering6▲ 23×1 topic
What research is done in Lianyungang?
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 8 works
- 2 HER2/EGFR in Cancer Research Oncology 7 works
- 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 6 works
- 4 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 5 works
- 5 Protein purification and stability Molecular Biology 4 works
- 6 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 4 works
- 7 Cancer-related molecular mechanisms research Cancer Research 4 works
- 8 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 4 works
- 9 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 4 works
- 10 Lung Cancer Research Studies Oncology 3 works
Research output over time
The same series as a ribbon — one cell per year, darker for more.